Latest Production Expansion News

Zip Co Limited (ASX: ZIP) reported a 46% rise in net profit to $116.4 million for FY26, driven by strong US and ANZ market growth and record cash earnings of $268.9 million. The company also announced an orderly wind down of its New Zealand operations to focus on its core markets.

Artrya Limited marked its first full year of US commercial operations with a $25.18 million loss, driven by regulatory clearances, customer contracts, and an $80 million capital raise.

MoneyMe Limited grew its loan book by 34% to $2.08 billion in FY26, boosted by record originations and improved credit quality, while reducing its net loss by 40%.

Cauldron Energy has begun trading on the US OTCQB market, broadening access to American investors without issuing new shares. This move taps into growing US demand for uranium, positioning Cauldron as a potential supplier from its Yanrey Uranium Project.

Tungsten Mining has kicked off a comprehensive 20,700-metre drilling campaign at its Watershed Tungsten Project, aiming to boost geological confidence and gather critical engineering data following strong economic results.

Life360 has surged past 100 million monthly active users, posting record revenue and subscriber growth in Q2 2026. Its AI-driven platform and expanding advertising business underpin strong profitability and a confident outlook.

Kaiser Reef has initiated underground development at the Union Hill Gold Mine, marking a significant step in unlocking the Maldon Gold Project's exploration and production potential.

Sea Forest Limited accelerated its commercial momentum in 4Q26 with an 83% revenue increase to $2.1 million, underpinned by new cattle supply agreements and the commissioning of its first regional distribution centre in Newcastle.

Kaiser Reef’s recent infill soil survey at the Maldon Gold Project reveals robust gold and arsenic anomalies, underpinning district-scale potential and setting the stage for targeted drilling following an airborne magnetic survey.

Echo IQ has locked in a strategic $20 million investment and US partnership with Pro Medicus, alongside a $110 million capital raise, positioning the company for accelerated commercial expansion of its AI-driven cardiovascular diagnostics in the US.

ECS Botanics plans to introduce two 2g all-in-one vape products under its OzSun brand in mid-August 2026, expanding its higher-margin B2C portfolio with a capital-efficient supply model.

Novonix has secured A$20.7 million from an institutional placement at a 33% discount, alongside a A$3 million Share Purchase Plan for existing shareholders, aiming to fund production capacity expansion amid growing battery demand.